Purchase

Multi-rAb HRP-Goat Anti-Mouse Recombinant Secondary Antibody (H+L)

Multi-rAb Goat Anti-Mouse Recombinant Secondary Antibody (H+L) is a mixture of precisely engineered recombinant monoclonal antibodies that recognize multiple complementary epitopes on the mouse IgG heavy and light chains.

Applications

ELISA, WB, Dot blot

Conjugate

HRP

Host

Goat

Reactivity

Mouse

Cat no : RGAM001


Product Information

RGAM001 targets Mouse IgG (H+L) in ELISA and Western blot. It can bind to all mouse IgG isotypes, mouse IgM and IgA as well as rat IgG. It shows minimal reactivity for rabbit, human, pig and bovine IgGs.

Concentration 1.0 mg/mL
Applications ELISA, WB, Dot blot
Host Species Goat
Species Reactivity Mouse
Physical State Liquid
Suggested Dilution Range 1:10,000-1:100,000 for ELISA
1:10,000-1:20,0000 for western blotting with ECL substrates (1:10,000-1:40,000 is suggested for most system).
Purity The antibody was purified from culture media supernatant by immunoaffinity chromatography using Protein G beads.
Storage Buffer PBS with 50% glycerol, 10 mg/mL BSA, 0.1% Proclin-300, pH 7.4.
Storage Instructions Store at -20°C. Stable for one year after shipment.
ClonalityMulticlonal recombinant
RRIDAB_3068333
NoteThis product is for research use only,not for diagnostic or therapeutic use.

Background

Multi-rAb Recombinant Secondary Antibodies are mixtures of precisely engineered recombinant monoclonal antibodies that recognize multiple complementary epitopes on the same IgG. Each recombinant clone in the final multiclonal mixture is carefully selected after rigorous characterization and screening to ensure the highest level of performance. ​The selected clones are mixed in various combinations, each of which is then functionally characterized in multiple applications to select the final multiclonal mixture with optimal performance. Each lot of Multi-rAb Secondary Antibodies is produced by mixing the same high performing recombinant clones every time to ensure that they have high batch-to-batch consistency, which in turn results in high reproducibility of experimental data.

Publications

Title

J Periodontol

Leukemia inhibitory factor protects against experimental periodontitis through immuno-modulations of both macrophages and periodontal ligament fibroblasts

Authors - Yanjing Ou

Mol Med

Targeting the NAT10/NPM1 axis abrogates PD-L1 expression and improves the response to immune checkpoint blockade therapy

Authors - Ge Qin